2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis.

@article{Heijde20112010UO,
  title={2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis.},
  author={D{\'e}sir{\'e}e Mfm van der Heijde and Joachim Sieper and Walter P. Maksymowych and Maxime R Dougados and Rub{\'e}n Burgos-Vargas and Robert B. M. Landew{\'e} and Mart{\'i}n Rudwaleit and J{\"u}rgen Braun},
  journal={Annals of the rheumatic diseases},
  year={2011},
  volume={70 6},
  pages={905-8}
}
This paper presents the second update of the Assessment in SpondyloArthritis international Society (ASAS) consensus statement on the use of anti-tumour necrosis factor (anti-TNF) agents in patients with axial spondyloarthritis (SpA). A major change from the previous recommendations is that patients fulfilling the ASAS axial SpA criteria, which also include… CONTINUE READING